Google has so many irons in the fire that it is not always easy to keep track of its projects. This is definitely not the case of the Google Library project, which proposes to scan the content of great libraries of the world and make them accessible to on-line search.

Unlike old generals, drug-patent wars not only do not die but do not even fade away. As reported by Reuters and other major media, on Monday, August 7, hundreds of Thais living with HIV/AIDS demonstrated in front of the Bangkok offices of drug maker GlaxoSmithKline to protest a patent application for its key anti-retroviral drug, Combid.

The nuclear industry really is interested in playing a role in the hydrogen economy, and meets regularly to review progress.

The UK's Small Business Investment Taskforce has looked into funding for high-tech businesses.

Would you trust a web search to deliver the evidence needed to change the law? That's an accusation made against the EU.

Is the UK really neglecting a clean source of energy? Before throwing money into fuel cells, potential investors might like to ask where the energy comes from.

The Department of Trade and Industry has set out a new set of priorities for its investment in R&D. The usual mixed bag, with a nod towards climate change.

Biotech start-ups in France and elsewhere in Europe make a unique and important contribution to healthcare. They merit special treatment to help them grow.

Blue biotech is getting into its stride, as the tools of genomics and high throughput screening are applied to unlock the chemical diversity of the oceans.

PharmaLinks, a business dedicated to commercialising pharmaceutical research, is looking for a development partner for an immunosuppressive cytokine with therapeutic potential in inflammatory diseases including rheumatoid arthritis, asthma, COPD and arteriosclerosis.